02.20.26 -- Sponsors Collect Too Much "Non-Essential" Data, Say Tufts And TransCelerate

Discover how digital innovation and patient-centric technologies are reshaping clinical trials by improving access, efficiency, and data-driven insights.

Fuel your clinical development and decision-making with insights from fit-for-purpose data and evidence.

Is your organization leveraging AI to maximize efficiency in safety and regulatory workflows? If not, explore how these technologies are slated to improve industry approaches in 2026.

AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.

Streamline your clinical trial study creation by automating and accelerating the eCOA build process. Generative AI models perform your repetitive configurations and significantly shorten build times.

With nearly three decades of successful application, NeuroCart remains a gold standard in CNS pharmacology, supporting precise, data-driven decisions in drug development.

Clinical sites use many different EHR and EMR systems, each with unique data structures. Explore flexible EHR to EDC solutions that allow teams to use this data without complex service engagements.

In today’s development landscape, where speed and resilience must go hand in hand, adopting a "Shift Left" mindset transforms testing from a bottleneck into a catalyst for innovation.

Ocular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.